Highlander Capital Management’s 2seventy bio TSVT Stock Holding History

Highlander Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.07K	Sell	200 -166	-45%	-$781	﹤0.01%	875
2023 Q4	$1.56K	Hold	366	–	–	﹤0.01%	888
2023 Q3	$1K	Hold	366	–	–	﹤0.01%	885
2023 Q2	$4K	Hold	366	–	–	﹤0.01%	616
2023 Q1	$4K	Hold	366	–	–	﹤0.01%	601
2022 Q4	$3K	Hold	366	–	–	﹤0.01%	585
2022 Q3	$5K	Buy	366 +134	+58%	+$1.99K	﹤0.01%	532
2022 Q2	$3K	Hold	232	–	–	﹤0.01%	582
2022 Q1	$4K	Hold	232	–	–	﹤0.01%	559
2021 Q4	$6K	Buy	+232	New	+$7.24K	﹤0.01%	510

Other funds holding TSVT

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Highlander Capital Management's TSVT Position: Q1 2024 in Review

Highlander Capital Management reduced its 2seventy bio (TSVT) stake by 45% in Q1 2024, selling an estimated $781 and leaving 200 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Highlander Capital Management first reported a position in TSVT in Q4 2021 and has held it in 10 quarters since. The position peaked at $6K in Q4 2021. 117 funds tracked by Wall St. Rank hold TSVT as of Q1 2024.

Highlander Capital Management held 200 shares of 2seventy bio worth $1.07K as of Q1 2024.
Highlander Capital Management sold 166 2seventy bio shares in Q1 2024, an estimated $781.
2seventy bio made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #875 holding.
Highlander Capital Management first reported a position in 2seventy bio in Q4 2021 and has held it in 10 quarters since.
Highlander Capital Management's 2seventy bio position peaked at $6K in Q4 2021.
117 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.